Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

20/20 Biolabs, Inc. (AIDX)

$0.52 -2.30% NASDAQ: AIDX · 15-min delayed
  • ROCKVILLE, Maryland
  • Public · NASDAQ: AIDX
  • 14 employees
$8.5MMarket cap
$2.0MRevenue · FY2025
-$3.7MNet income
14Employees
AIDXNASDAQ
2026IPO

About 20/20 Biolabs, Inc.

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$2.0M
Net income
-$3.7M
Total assets
$4.1M
Market cap
$8.5M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: AIDX
$0.52 -2.30%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.52 $23.85

52-week range

Market cap
$8.5M
Shares outstanding
16.4M
Open
Day range
Prev close
Volume
IPO date
Feb 19, 2026

20/20 Biolabs, Inc. (AIDX) Stock Price

  • Reported a net loss of $3.7M in FY2025.
  • Trading 98% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review 20/20 Biolabs, Inc..

Write a review
Newsroom

News about 20/20 Biolabs, Inc.

News & sentiment via Polygon.io

FAQ

20/20 Biolabs, Inc.: frequently asked questions

Is 20/20 Biolabs, Inc. an American company?

20/20 Biolabs, Inc. is a US-based company headquartered in Rockville, Maryland, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is 20/20 Biolabs, Inc. headquartered?

20/20 Biolabs, Inc. is headquartered in Rockville, Maryland, United States.

Is 20/20 Biolabs, Inc. publicly traded?

Yes — 20/20 Biolabs, Inc. is a publicly traded company. Its stock trades under the ticker symbol AIDX on the NASDAQ.

What does 20/20 Biolabs, Inc. do?

20/20 Biolabs, Inc. is an American Professional Services company in the Business & Financial Services sector.

Explore

Similar companies

Browse all →